KP Tissue Inc. (TSE:KPT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$8.77 and traded as high as C$9.50. KP Tissue shares last traded at C$9.50, with a volume of 5,589 shares.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on KPT shares. Desjardins raised their price objective on KP Tissue from C$9.50 to C$10.00 and gave the company a "hold" rating in a report on Thursday, August 14th. National Bankshares raised their price objective on KP Tissue from C$9.50 to C$10.00 and gave the company a "sector perform" rating in a report on Thursday, August 14th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, KP Tissue currently has an average rating of "Hold" and a consensus price target of C$9.38.
Read Our Latest Report on KP Tissue
KP Tissue Stock Performance
The stock has a market capitalization of C$95.01 million, a PE ratio of 21.59, a price-to-earnings-growth ratio of -0.88 and a beta of 0.19. The firm's fifty day moving average is C$9.34 and its 200-day moving average is C$8.79.
KP Tissue Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Tuesday, September 30th will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 7.6%. KP Tissue's dividend payout ratio (DPR) is currently 163.64%.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
Featured Articles
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
